Showing results (81-90 of 200) with videos related to
Sort By:
Pageof 20
Frontiers in Oncology|December 20, 2018
Contribution of MUTYH Variants to Male Breast Cancer Risk: Results From a Multicenter Study in ItalyPiera Rizzolo, Valentina Silvestri, Agostino Bucalo, et al.Breast Cancer Research and Treatment|October 19, 2013
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutationAdriana Valentini, Jan Lubinski, Tomasz Byrski, et al.Cancer|September 21, 2016
Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility geneValentina Silvestri, Veronica Zelli, Virginia Valentini, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 25, 2017
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragilityIrene Catucci, Ana Osorio, Brita Arver, et al.Journal of Medical Genetics|October 12, 2012
Rare variants in XRCC2 as breast cancer susceptibility allelesFlorentine S Hilbers, Juul T Wijnen, Nicoline Hoogerbrugge, et al.Investigative Radiology|December 9, 2010
Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final resultsFrancesco Sardanelli, Franca Podo, Filippo Santoro, et al.Journal of the American Academy of Dermatology|June 9, 2009
Clinical genetic testing for familial melanoma in Italy: a cooperative studyWilliam Bruno, Paola Ghiorzo, Linda Battistuzzi, et al.Cancers|February 12, 2021
Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern ItalyGisella Figlioli, Arcangela De Nicolo, Irene Catucci, et al.Radiology|January 25, 2007
Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim resultsFrancesco Sardanelli, Franca Podo, Giuliano D'Agnolo, et al.Human Mutation|July 4, 2012
Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target siteBrooke L Brewster, Francesca Rossiello, Juliet D French, et al.Pageof 20